Dominant genetic alterations in immortalization: role for 20q gain

Area of Science:

• Cancer Biology
• Genetics
• Cellular Senescence

Background:

• Gain of chromosome 20q is frequent in cancers, but its role in early pathogenesis, particularly low-copy gains, remains unclear.
• Human papillomavirus 16 (HPV 16) E7 transformation of human uroepithelial cells (HUC) is linked to single-copy 20q gain and immortalization.
• Cellular senescence is a critical barrier to tumor development, and mechanisms of bypassing it are central to cancer research.

Purpose of the Study:

• To investigate the hypothesis that low-copy gain of 20q genes contributes dominantly to bypassing HUC senescence.
• To determine if dominant genetic alterations can drive immortalization, challenging the prevailing view of recessive changes.

Main Methods:

• Fusion of precrisis E7-transformed HUCs (pcE7s) with immortal E7-HUCs exhibiting single-copy 20q gain.
• Analysis of cytogenetic alterations, including single-copy 20q gain and 10p12.1-pter loss.
• Confirmation of hybrid cell nature using Southern analysis for HPV16 insertion sites and FISH with chromosome 20 probes.

Main Results:

• Immortal cell hybrids were successfully generated by fusing pcE7s with E7-HUCs possessing a single-copy 20q gain.
• In contrast, fusion of precrisis E6-transformed HUCs (pcE6s) with E6-HUCs lacking 20q gain did not yield immortal hybrids.
• These findings indicate that dominant genetic changes, specifically on 20q, can facilitate the bypass of senescence.

Conclusions:

• This study provides the first evidence that dominant genetic alterations can contribute to bypassing cellular senescence.
• Genes located on chromosome 20q may play a significant role in cancer pathogenesis by enabling cells to overcome senescence.
• The findings challenge the exclusive paradigm of recessive genetic events in cell immortalization and cancer development.